AtriCure reports Q3 preliminary revenue $49.9M, consensus $46.76M

AtriCure’s preliminary and unaudited revenue for the third quarter of 2018 is expected to be approximately $49.9M, reflecting growth of approximately 18.5% over the third quarter of 2017 (18.6% on a constant currency basis). Based on this preliminary estimate, U.S. revenue is expected to be approximately $39.8M, reflecting growth of 19.1% over the third quarter of 2017. International revenue is expected to be approximately $10.2M, an increase of 16.2% as compared to the third quarter of 2017 (16.9% on a constant currency basis).
https://thefly.com/landingPageNews.php?id=2799369